Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Albuterol | 6 | 2006 | 26 | 1.000 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2022 | 56 | 0.850 |
Why?
|
| Bronchodilator Agents | 5 | 2006 | 43 | 0.850 |
Why?
|
| Hypernatremia | 1 | 2021 | 7 | 0.810 |
Why?
|
| Asthma | 2 | 2022 | 345 | 0.770 |
Why?
|
| Medication Errors | 3 | 2015 | 116 | 0.720 |
Why?
|
| Hyperglycemia | 1 | 2021 | 158 | 0.700 |
Why?
|
| Drug Prescriptions | 2 | 2015 | 135 | 0.590 |
Why?
|
| Respiration, Artificial | 6 | 2006 | 190 | 0.540 |
Why?
|
| Late Onset Disorders | 1 | 2015 | 4 | 0.530 |
Why?
|
| Sepsis | 1 | 2015 | 233 | 0.420 |
Why?
|
| Infant | 11 | 2021 | 2891 | 0.390 |
Why?
|
| Anti-Bacterial Agents | 2 | 2015 | 1026 | 0.390 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2022 | 186 | 0.370 |
Why?
|
| Nebulizers and Vaporizers | 4 | 2002 | 34 | 0.360 |
Why?
|
| Helium | 2 | 2006 | 9 | 0.340 |
Why?
|
| Education, Pharmacy | 3 | 2018 | 102 | 0.320 |
Why?
|
| Analgesics, Opioid | 3 | 2020 | 498 | 0.320 |
Why?
|
| Metered Dose Inhalers | 1 | 2006 | 4 | 0.290 |
Why?
|
| Infant, Newborn | 7 | 2021 | 2453 | 0.290 |
Why?
|
| Oxygen | 2 | 2006 | 386 | 0.290 |
Why?
|
| Administration, Inhalation | 3 | 2022 | 187 | 0.250 |
Why?
|
| Drug Combinations | 2 | 2022 | 304 | 0.250 |
Why?
|
| Lung | 2 | 2006 | 849 | 0.230 |
Why?
|
| Budesonide | 1 | 2022 | 10 | 0.230 |
Why?
|
| Ethanolamines | 1 | 2022 | 33 | 0.220 |
Why?
|
| Formoterol Fumarate | 1 | 2022 | 25 | 0.220 |
Why?
|
| Internship, Nonmedical | 2 | 2012 | 19 | 0.200 |
Why?
|
| Parenteral Nutrition | 1 | 2021 | 39 | 0.200 |
Why?
|
| Infant, Premature | 3 | 2021 | 284 | 0.200 |
Why?
|
| High-Frequency Ventilation | 1 | 2000 | 4 | 0.190 |
Why?
|
| Inappropriate Prescribing | 1 | 2020 | 27 | 0.190 |
Why?
|
| Drug Delivery Systems | 3 | 1999 | 236 | 0.180 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2020 | 69 | 0.180 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 91 | 0.180 |
Why?
|
| Models, Cardiovascular | 1 | 2000 | 133 | 0.180 |
Why?
|
| Pneumonia | 1 | 2020 | 110 | 0.170 |
Why?
|
| Humans | 23 | 2022 | 68525 | 0.170 |
Why?
|
| Prospective Studies | 5 | 2015 | 3702 | 0.170 |
Why?
|
| Propanolamines | 3 | 1998 | 70 | 0.170 |
Why?
|
| Pediatrics | 3 | 2015 | 341 | 0.160 |
Why?
|
| Pharmacy Residencies | 1 | 2018 | 18 | 0.160 |
Why?
|
| Students, Pharmacy | 3 | 2018 | 79 | 0.160 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2015 | 113 | 0.150 |
Why?
|
| Incidence | 1 | 2021 | 1582 | 0.150 |
Why?
|
| Acetaminophen | 1 | 2017 | 111 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 772 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 503 | 0.130 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 1998 | 189 | 0.130 |
Why?
|
| Child | 8 | 2020 | 6400 | 0.130 |
Why?
|
| Sinusitis | 1 | 2020 | 432 | 0.120 |
Why?
|
| Drug Overdose | 1 | 2015 | 67 | 0.120 |
Why?
|
| Atenolol | 1 | 1994 | 20 | 0.120 |
Why?
|
| Chorioamnionitis | 1 | 2014 | 40 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 711 | 0.120 |
Why?
|
| Child, Preschool | 6 | 2020 | 3185 | 0.120 |
Why?
|
| Schools, Pharmacy | 2 | 2012 | 36 | 0.120 |
Why?
|
| Placenta | 1 | 2014 | 101 | 0.120 |
Why?
|
| Patient Safety | 1 | 2015 | 202 | 0.120 |
Why?
|
| Time Management | 1 | 2013 | 12 | 0.110 |
Why?
|
| Symptom Assessment | 1 | 2013 | 33 | 0.110 |
Why?
|
| Time-to-Treatment | 1 | 2013 | 117 | 0.100 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 317 | 0.100 |
Why?
|
| Alfentanil | 1 | 1991 | 1 | 0.100 |
Why?
|
| Hyaline Membrane Disease | 1 | 1991 | 10 | 0.100 |
Why?
|
| Acetylcysteine | 1 | 2014 | 296 | 0.100 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 1991 | 15 | 0.100 |
Why?
|
| Cross Infection | 1 | 2013 | 195 | 0.100 |
Why?
|
| Irritable Mood | 1 | 2009 | 15 | 0.090 |
Why?
|
| Respiratory Mechanics | 2 | 2002 | 33 | 0.090 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2009 | 60 | 0.090 |
Why?
|
| Amines | 1 | 2009 | 98 | 0.080 |
Why?
|
| Women | 1 | 2008 | 40 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 142 | 0.080 |
Why?
|
| Analgesics | 1 | 2009 | 118 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2009 | 208 | 0.080 |
Why?
|
| Research | 1 | 2008 | 214 | 0.070 |
Why?
|
| Infusions, Intravenous | 3 | 2014 | 334 | 0.070 |
Why?
|
| Aerosols | 1 | 2006 | 42 | 0.070 |
Why?
|
| Pain | 1 | 2009 | 472 | 0.070 |
Why?
|
| Curriculum | 3 | 2018 | 575 | 0.070 |
Why?
|
| Medicaid | 2 | 2020 | 301 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 765 | 0.070 |
Why?
|
| South Carolina | 3 | 2020 | 2750 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2014 | 1737 | 0.060 |
Why?
|
| United States | 4 | 2020 | 7335 | 0.060 |
Why?
|
| Respiration Disorders | 1 | 2002 | 20 | 0.050 |
Why?
|
| Catheterization, Peripheral | 1 | 2002 | 38 | 0.050 |
Why?
|
| Drug Stability | 4 | 1995 | 71 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 1999 | 381 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2002 | 260 | 0.050 |
Why?
|
| Glucose | 2 | 1995 | 307 | 0.050 |
Why?
|
| Clinical Competence | 2 | 2018 | 657 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2013 | 502 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 1995 | 618 | 0.050 |
Why?
|
| Heart Rate | 1 | 2002 | 568 | 0.050 |
Why?
|
| Female | 8 | 2020 | 38015 | 0.040 |
Why?
|
| Societies, Pharmaceutical | 1 | 2018 | 22 | 0.040 |
Why?
|
| Male | 7 | 2020 | 37281 | 0.040 |
Why?
|
| Aortic Coarctation | 1 | 1998 | 37 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 193 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2020 | 339 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2020 | 284 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2020 | 225 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 2798 | 0.040 |
Why?
|
| Drug Contamination | 2 | 1994 | 10 | 0.040 |
Why?
|
| Drug Storage | 2 | 1994 | 16 | 0.040 |
Why?
|
| Drug Compounding | 2 | 1994 | 34 | 0.040 |
Why?
|
| Solutions | 2 | 1994 | 115 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2000 | 705 | 0.040 |
Why?
|
| Logistic Models | 1 | 2020 | 1419 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 1996 | 45 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2002 | 1447 | 0.030 |
Why?
|
| Dosage Forms | 1 | 2015 | 20 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1996 | 137 | 0.030 |
Why?
|
| Drug Labeling | 1 | 2015 | 32 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2015 | 62 | 0.030 |
Why?
|
| Fetus | 1 | 1996 | 157 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2015 | 141 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2014 | 57 | 0.030 |
Why?
|
| Outpatients | 1 | 2015 | 127 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2014 | 131 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2014 | 112 | 0.030 |
Why?
|
| Mothers | 1 | 2014 | 172 | 0.030 |
Why?
|
| Intensive Care, Neonatal | 1 | 2013 | 38 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 1998 | 596 | 0.030 |
Why?
|
| Flecainide | 1 | 1992 | 3 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1998 | 1745 | 0.030 |
Why?
|
| Pregnancy | 2 | 2014 | 2331 | 0.030 |
Why?
|
| Amphotericin B | 1 | 1991 | 26 | 0.030 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2012 | 52 | 0.030 |
Why?
|
| Fluconazole | 1 | 1991 | 26 | 0.030 |
Why?
|
| Candidiasis | 1 | 1991 | 39 | 0.030 |
Why?
|
| Career Choice | 1 | 2012 | 98 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 1991 | 48 | 0.020 |
Why?
|
| Half-Life | 1 | 1991 | 96 | 0.020 |
Why?
|
| Drug Incompatibility | 1 | 1990 | 7 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 1991 | 85 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 1998 | 1615 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1341 | 0.020 |
Why?
|
| Models, Biological | 1 | 1994 | 981 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1991 | 239 | 0.020 |
Why?
|
| Internet | 1 | 2012 | 390 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2013 | 413 | 0.020 |
Why?
|
| Hypertension | 1 | 1998 | 1531 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1996 | 2550 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 420 | 0.020 |
Why?
|
| Pharmacy | 1 | 2008 | 26 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 1030 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 8903 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 4655 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 7264 | 0.010 |
Why?
|
| Models, Structural | 1 | 1999 | 22 | 0.010 |
Why?
|
| Infusion Pumps | 1 | 1996 | 39 | 0.010 |
Why?
|
| Laparotomy | 1 | 1996 | 65 | 0.010 |
Why?
|
| Uterus | 1 | 1996 | 77 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1995 | 134 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1996 | 172 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1996 | 163 | 0.010 |
Why?
|
| Catheterization | 1 | 1996 | 209 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 1996 | 159 | 0.010 |
Why?
|
| Equipment Design | 1 | 1996 | 500 | 0.010 |
Why?
|
| Swine | 1 | 1996 | 672 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 21375 | 0.010 |
Why?
|
| Suspensions | 1 | 1992 | 11 | 0.010 |
Why?
|
| Injections | 1 | 1991 | 119 | 0.010 |
Why?
|
| Bacteria | 1 | 1992 | 193 | 0.010 |
Why?
|
| Temperature | 1 | 1992 | 340 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1990 | 22 | 0.010 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 1990 | 35 | 0.010 |
Why?
|
| Animals | 1 | 1996 | 20877 | 0.000 |
Why?
|